Total Payments
$84,905
2024 Payments
$930.65
Companies
37
Transactions
403
Medicare Patients
12,835
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$68,118 (80.2%)
Food & Beverage$9,437 (11.1%)
Travel$6,213 (7.3%)
Consulting$1,000 (1.2%)
Education$136.24 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $68,118 | 32 | 80.2% |
| Food and Beverage | $9,437 | 330 | 11.1% |
| Travel and Lodging | $6,213 | 34 | 7.3% |
| Consulting Fee | $1,000 | 4 | 1.2% |
| Education | $136.24 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $43,472 | 95 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $18,955 | 39 | $0 (2024) |
| PFIZER INC. | $11,091 | 35 | $0 (2024) |
| Medtronic Vascular, Inc. | $4,717 | 36 | $0 (2020) |
| Abbott Laboratories | $2,113 | 24 | $0 (2022) |
| Boston Scientific Corporation | $1,283 | 17 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $480.13 | 40 | $0 (2024) |
| Edwards Lifesciences Corporation | $444.27 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $295.95 | 16 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $255.64 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $930.65 | 45 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($205.34) |
| 2023 | $1,116 | 49 | HeartFlow, Inc. ($207.44) |
| 2022 | $860.26 | 42 | Edwards Lifesciences Corporation ($181.27) |
| 2021 | $4,376 | 17 | Amgen Inc. ($4,183) |
| 2020 | $12,091 | 17 | Amgen Inc. ($12,034) |
| 2019 | $19,979 | 74 | Amgen Inc. ($10,316) |
| 2018 | $26,872 | 87 | Amgen Inc. ($14,705) |
| 2017 | $18,680 | 72 | E.R. Squibb & Sons, L.L.C. ($11,062) |
All Payment Transactions
403 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $8.33 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/06/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $7.28 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/23/2024 | Philips North America LLC | (P77) Azurion 7 M20 (Device) | Food and Beverage | Cash or cash equivalent | $118.50 | General |
| Category: Medical Device | ||||||
| 11/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Cardiology | ||||||
| 11/16/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Renal Denervation System | ||||||
| 11/14/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $51.33 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/06/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.50 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $7.99 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $7.29 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.65 | General |
| Category: Cardiovascular | ||||||
| 09/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.26 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Obesity | ||||||
| 09/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/05/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.47 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/21/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/21/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.97 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.45 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/31/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.99 | General |
| Category: Cardiovascular | ||||||
| 07/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Cardiology | ||||||
| 06/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.82 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Cardiology | ||||||
| 06/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.71 | General |
| Category: Cardiovascular | ||||||
| 06/03/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.27 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,385 | 3,780 | $1.0M | $231,526 |
| 2022 | 28 | 3,265 | 4,768 | $1.1M | $242,148 |
| 2021 | 28 | 3,400 | 4,655 | $1.1M | $308,886 |
| 2020 | 28 | 3,785 | 5,673 | $1.3M | $363,005 |
Total Patients
12,835
Total Services
18,876
Medicare Billing
$1.1M
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 804 | 1,276 | $322,828 | $76,183 | 23.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 352 | 530 | $196,100 | $47,559 | 24.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 69 | 69 | $113,091 | $23,860 | 21.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 124 | 124 | $104,532 | $16,880 | 16.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 61 | 244 | $47,336 | $10,963 | 23.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $33,099 | $6,992 | 21.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 35 | 70 | $15,960 | $6,143 | 38.5% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 33 | 64 | $13,312 | $5,895 | 44.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 107 | 108 | $27,216 | $5,735 | 21.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 68 | 68 | $25,160 | $5,122 | 20.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 65 | 65 | $17,615 | $3,866 | 21.9% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 11 | 66 | $6,468 | $3,735 | 57.8% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 41 | 62 | $16,536 | $3,654 | 22.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 49 | 143 | $16,302 | $2,977 | 18.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 54 | 55 | $16,115 | $2,803 | 17.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 61 | 172 | $16,340 | $2,785 | 17.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 193 | 203 | $14,819 | $1,956 | 13.2% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 13 | 33 | $7,458 | $897.90 | 12.0% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 48 | 49 | $3,773 | $819.28 | 21.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 69 | 71 | $3,621 | $773.50 | 21.4% |
| 85610 | Blood test, clotting time | Office | 2023 | 13 | 160 | $2,400 | $672.00 | 28.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 13 | 46 | $3,588 | $635.61 | 17.7% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 16 | 16 | $1,440 | $323.84 | 22.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 27 | 27 | $1,377 | $298.35 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 832 | 1,266 | $320,298 | $77,082 | 24.1% |
About Dr. Marc Unterman, MD
Dr. Marc Unterman, MD is a Cardiovascular Disease healthcare provider based in Lawrenceville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1427044858.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marc Unterman, MD has received a total of $84,905 in payments from pharmaceutical and medical device companies, with $930.65 received in 2024. These payments were reported across 403 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($68,118).
As a Medicare-enrolled provider, Unterman has provided services to 12,835 Medicare beneficiaries, totaling 18,876 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Lawrenceville, GA
- Active Since 09/21/2005
- Last Updated 06/28/2013
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1427044858
Products in Payments
- Repatha (Biological) $43,296
- ELIQUIS (Drug) $29,764
- Resolute (Device) $4,729
- Omnilink Elite vascular stent system (Device) $1,827
- ANGIOJET (Device) $726.93
- LifeVest (Device) $480.13
- XARELTO (Drug) $255.64
- VERQUVO (Drug) $249.98
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $232.64
- FFRct (Device) $219.53
- ENTRESTO (Drug) $179.96
- GENERAL VASCULAR ACCESS (Device) $177.92
- Corlanor (Drug) $175.92
- SAPIEN 3 Ultra RESILIA (Device) $151.30
- GENERAL STENTS (Device) $134.47
- CardioMEMS HF System (Device) $133.74
- GENERAL - STENTS (Device) $130.25
- (P77) Azurion 7 M20 (Device) $118.50
- CHANTIX (Drug) $116.93
- LEQVIO (Drug) $115.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Lawrenceville
Dr. Yuri Pride, M.d, M.D
Cardiovascular Disease — Payments: $225,237
Cardiovascular Disease $225,237
Niraj Sharma, Md, MD
Cardiovascular Disease — Payments: $122,462
Cardiovascular Disease $122,462
Dr. Demir Baykal, Md, MD
Cardiovascular Disease — Payments: $96,968
Cardiovascular Disease $96,968
Dr. Zabeer Bhatti, M.d, M.D
Cardiovascular Disease — Payments: $51,853
Cardiovascular Disease $51,853
Philip Romm, Md, MD
Cardiovascular Disease — Payments: $48,430
Cardiovascular Disease $48,430
Dr. Marcus Sims, M.d, M.D
Cardiovascular Disease — Payments: $48,048
Cardiovascular Disease $48,048